Predictive model of risk for the early diagnosis of type II diabetes mellitus
Keywords:
type II diabetes mellitus, early diagnosis, predictive model.Abstract
Introduction: The early diagnosis of the type II diabetes mellitus allows the health staff to implement strategies in order to avoid the chronic complications that could be derived. To such effects, in the last two decades predictive models have been developed that include more variables every day.
Objective: To elaborate a predictive model for the early diagnosis of type II diabetes mellitus in a population from Holguín.
Methods: A cohort study was carried out that included all the patients assisted in the endocrinology services of Pedro Díaz Coello health area and Fermín Valdés Domínguez Military Hospital in Holguín province, for which 2 cohorts were taken: one of analysis and another of validation. For the statistical processing the univaried and multivaried analysis were carried out; as long as the association between dependent and independent variables was determined.
Results: In the series there was a prevalence of the female sex, patients without history of diabetes mellitus and hypertension, as well as those that presented hypothyroidism, periodontal disease and normal weight, among others; also, the pattern was statistically significant (X2=31.1 and p=0.000) and explained 80.9 % of the logout variable validated by the analysis variables. The sensibility was of 96.9 % and the specificity of 86.6 %; while the area under the curve had a range from 0.725 to 0.833.
Conclusions: The predictive model elaborated is a very useful tool for the diagnosis of patients with risk of type II diabetes mellitus.
Downloads
References
2. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 [citado 12/08/2022];26(3):725-31. Disponible en: https://diabetesjournals.org/care/article/26/3/725/29197/The-Diabetes-Risk-ScoreA-practical-tool-to-predict
3. Von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab. 2000 [citado 12/08/2022];85(9). Disponible en: https://academic.oup.com/jcem/article/85/9/3101/2660492
4. Soliman N, El-Shabrawi M, Omar S. DNA fragmentation damage as a predictive marker for diabetic nephropathy in type II diabetes mellitus. J Endocrinol Metab Diabetes S Afr. 2018 [citado 12/08/2022];23(2):32–5. Disponible en: https://journals.co.za/doi/pdf/10.1080/16089677.2018.1434033
5. Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AM, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. 2012 [citado 12/08/2022];345:e5900. Disponible en: https://www.bmj.com/content/345/bmj.e5900
6. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001 [citado 12/08/2022];50(10). Disponible en: https://diabetesjournals.org/diabetes/article/50/10/2384/19414/The-Relation-of-Markers-of-Inflammation-to-the
7. Silvestre MP, Jiang Y, Volkova K, Chisholm H, Lee W, Poppitt SD. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort. Prim Care Diabetes. 2017;11(6):561-9.
8. Lim HM, Chia YC, Koay ZL. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care. Prim Care Diabetes. 2020 [citado 12/08/2022];14(5):494-500. Disponible en: https://www.primary-care-diabetes.com/article/S1751-9918(18)30186-4/fulltext
9. Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, et al. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study. Eur J Endocrinol. 2019 [citado 12/08/2022];181(2):185-92. Disponible en: https://eje.bioscientifica.com/view/journals/eje/181/2/EJE-19-0143.xml
10. Rokhman MR, Arifin B, Zulkarnain Z, Satibi S, Perwitasari DA, Boersma C, et al. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population. PLoSOne. 2022 [citado 12/08/2022];17(7):e0269853. Disponible en: https://doi.org/10.1371/journal.pone.0269853
11. Abdallah M, Sharbaji S, Sharbaji M, Daher Z, Faour T, Mansour Z, et al. Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Diabetol Metab Syndr. 2020 [citado 12/08/2022];12:84. Disponible en: https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-020-00590-8
12. Awad SF, Dargham SR, Toumi AA, Dumit EM, El-Nahas KG, Al-Hamaq AO, et al. A diabetes risk score for Qatar utilizing a novel mathematical modeling approach to identify individuals at high risk for diabetes. Sci Rep. 2021 [citado 12/08/2022];11(1):1811. Disponible en: https://www.nature.com/articles/s41598-021-81385-3
13. Sulaiman N, Mahmoud I, Hussein A, Elbadawi S, Abusnana S, Zimmet P, et al. Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2018 [citado 12/08/2022];6(1). Disponible en: https://drc.bmj.com/content/6/1/e000489
14. Bahijri S, Al-Raddadi R, Ajabnoor G, Jambi H, Al Ahmadi J, Borai A, et al. Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes. J Diabetes Investig. 2020 [citado 12/08/2022];11(4):844-55. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/jdi.13213
15. Stiglic G, Wang F, Sheikh A, Cilar L. Development and validation of the type 2 diabetes mellitus 10-year risk score prediction models from survey data. Prim Care Diabetes. 2021;15(4):699-705. DOI: 10.1016/j.pcd.2021.04.008
16. Heltberg A, Andersen JS, Sandholdt H, Siersma V, Kragstrup J, Ellervik C. Predictors of undiagnosed prevalent type 2 diabetes – The Danish General Suburban Population Study. Prim Care Diabetes. 2018;12(1):13-22. doi: 10.1016/j.pcd.2017.08.005
17. Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim Care Diabetes. 2018 [citado 12/08/2022];12(6):517-25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249987/
18. Nieto Martínez R, González Rivas JP, Ugel E, Marulanda MI, Durán M, Mechanick JI, et al. External validation of the Finnish diabetes risk score in Venezuela using a national sample: The EVESCAM. Prim Care Diabetes. 2019 [citado 12/08/2022];13(6):574-82. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1751991818303346
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
